Evaluation agreements allow a party to the deal to obtain rights to a technology or compound, subject to... Read the full story
Evaluation agreements allow a party to the deal to obtain rights to a technology or compound, subject to... Read the full story
The article here analyses the recent partnering industry trends in the option and evaluation deal type areas. There are two major forms of deal terms that allow a party to secure rights to an asset subject to a future event Read the full story
Global Green announces the signing of an agreement with Merial to conduct an internal evaluation of Global Green’s patented Salmogenics vaccine technology.
Arrowhead Research Corporation announced signing of new pharma deals with Merck, through a subsidiary, to undertake an evaluation of a novel proprietary therapeutic monoclonal antibody candidate derived from Arrowhead’s human-derived peptide targeting and discovery program.
The Option and Evaluation Agreements in Pharma and Biotech report provides comprehensive understanding and unprecedented access to the option and evaluation partnering agreements entered into by the worlds leading biopharma companies. Read the full story